Survival, weight loss, translocation and histological alterations in the terminal ileum, liver and spleen were studied in mice simultaneously immunosuppressed with cyclophosphamide and treated or not with Saccharomyces boulardii until the death of all animals. The animals were divided into five groups: C1 (not immunosuppressed, not treated); C2 (immunosuppressed, not treated); B1 (immunosuppressed, treated with S. boulardii 10.0 mg); B2 (immunosuppressed, treated with S. boulardii 1.0 mg) and B3 (immunosuppressed, treated with S. boulardii 0.1 mg). Survival was higher in group B3 than in the other immunosuppressed groups. Weight loss was observed for all groups except C1. By day 7, some animals from each group were killed by ether inhalation for the determination of bacterial translocation and histopathological examination. Bacterial translocation to the liver was lower in groups C1 and B3 than in the other groups. The highest translocation to the liver and spleen was observed in group B1. Low S. boulardii translocation was observed in some animals, principally to the mesenteric lymph nodes. Histopathological examination showed a decrease in epithelial cell turnover with villus length reduction and loss of brush borders in group C2. Relative protection against these alterations was obtained when the animals were treated with the yeast, independently of the dose. Higher expression of the lymphoid component was also noted in the ileal lamina propria, liver and spleen of mice treated with the yeast, together with activation of the reticulo-endothelial system, when compared with group C2 where lymphocyte depletion was observed. This study suggests a relative protection of immunosuppressed animals by treatment with S. boulardii, but this phenomenon was inversely proportional to the yeast dose.
BergR. D.,
GarlingtonA. W. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun1979; 23:403–411
MorehouseJ. L.,
SpecianR. D.,
StewartJ. J.,
BergR. D. Translocation of indigenous bacteria from the gastrointestinal tract of mice after oral ricinoleic acid treatment. Gastroenterology1986; 91:673–682
ElmerG. W.,
SurawiczC. M.,
McFarlandL. V. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA1996; 275:870–876
CaetanoJ. A. M.,
ParamesM. T.,
BaboM. J. Immunopharma-cological effects of Saccharomyces boulardii in healthy human volunteers. Int J Immunopharmacol1986; 8:245–259
BergR.,
BemasconiP.,
FowlerD.,
GautreauxM. Inhibition of Candida albicans translocation from the gastrointestinal tract of mice by oral administration of Saccharomyces boulardii. J Infect Dis1993; 168:1314–1318
Saint-MarcT.,
Rossello-PratsL.,
TouraineJ. L. Efficacite de Saccharomyces boulardii dans le traitement des diarrhees du SIDA. Ann Med Interne (Paris)1991; 142:64–65
KlaterskyJ. Therapy of bacterial infections in cancer patients. In
VerhoeftP.,
PetersonP. K.,
QuieP. G.
(eds) Infections in the immunocompromised host-Pathogenesis, prevention and therapy Amsterdam: Elsevier/North Holland Publishing Co; 1980207–299
WittD. J.,
CravenD. E.,
McCabeW. R. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Am J Med1987; 82:900–906
GautreauxM. D.,
DeitchE. A.,
BergR. D. T lymphocytes in host defense against bacterial translocation from the gastrointestinal tract. Infect Immun1994; 62:2874–2884
KatzS.,
JimenezM. A.,
LehmkuhlerW. E.,
GrosfeldJ. L. Liver bacterial clearance following hepatic artery ligation and portacaval shunt. J Surg Res1991; 51:267–270
DucluzeauR.,
BensaadaM. Effet compare de l’administration unique ou en continu de Saccharomyces boulardii sur l’etablissement de diverses souches de Candida dans le tractus digestif de souris gnotoxéniques. [Comparative effect of a single or continuous administration of “ Saccharomyces boulardii” on the establishment of various strains of “Candida” in the digestive tract of gnotobiotic mice.]. Ann Microbiol1982; 133:491–501
RodriguesA. C. P.,
NardiR. M.,
BambirraE. A.,
VieiraE. C.,
NicoliJ. R. Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. J Appl Bacteriol1996; 81:251–256
MatsuoT.,
KurahashiY.,
NishidaS.,
OnoderaC.,
IzawaM.,
HamuroJ. Effect of lentinan, a specific T-cell adjuvant, on murine granulopoiesis and its roles on antitumor effect. Int J Immunopharmacol1982; 4:269 (Abstract)
HamuroJ.,
AkiyamaY.,
IguchiY.,
IsawaM.,
MatsuoT. Distinct roles of serum factors induced by a T cell specific immune adjuvant lentinan in cellular immune responses. Int J Immunopharmacol1982; 4:268 (Abstract)
DiasR. S.,
BambirraE. A.,
SilvaM. E.,
NicoliJ. R. Protective effect of Saccharomyces boulardii against the cholera toxin in rats. Braz J Med Biol Res1995; 28:323–325
NeumannE.,
OliveiraM. A.,
PéretL. A. The probiotic stimulation of the host mononuclear phagocyte system in gnotobiotic and conventional mice. XIIth International Symposium on Gnotobiology1996 Honolulu, Hawaii: Abstract S-28